16 JUNE 2005

NEW ZEALAND GAZETTE, No. 91

2139

Product:
Eprex (notification received 4 June 2004)
Active Ingredient:
Epoetin alfa 336µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Cilag AG, Schaffhausen, Switzerland

Product:
Eprex (notification received 6 August 2004)
Active Ingredient:
Epoetin alfa 84µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Product:
Eprex (notification received 6 August 2004)
Active Ingredient:
Epoetin alfa 16.8µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Product:
Eprex (notification received 6 August 2004)
Active Ingredient:
Epoetin alfa 33.6µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Product:
Eprex (notification received 6 August 2004)
Active Ingredient:
Epoetin alfa 336µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Cilag AG, Schaffhausen, Switzerland

Product:
ImmuCyst BCG Immunotherapeutic vaccine
Active Ingredient:
Tuberculin purified protein derivative 81mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturer:
Aventis Pasteur Limited, Toronto, Ontario, Canada

Dated this 9th day of June 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3674

Inland Revenue

Tax Administration Act 1994

Notice of Public Ruling

1. This is a notice of a public ruling made under section 91D of the Tax Administration Act 1994.

2. Public ruling BR Pub 05/02 entitled "Disposition of real property for inadequate consideration where following a grant of a life estate the balance is transferred to another person—Gift duty and income tax implications" was issued on 8 June 2005. The ruling’s subject matter was originally contained in BR Pub 02/02, which applied from 1 April 1999 to 31 March 2005. BR Pub 05/02 applies on 1 April 2005 for an indefinite period. It will appear in Inland Revenue’s Tax Information Bulletin, Vol. 17, No. 5, of June 2005.

3. A copy of the ruling may be obtained by writing to the Manager, Field Liaison & Communication (Adjudication & Rulings), National Office, Inland Revenue, P.O. Box 2198, Wellington.

RANGI KRISHNAN, Manager, Field Liaison & Communication (Adjudication & Rulings).

go3641

Notice of Public Ruling

1. This is a notice of a public ruling made under section 91D of the Tax Administration Act 1994.

2. Public ruling BR Pub 05/03 entitled "Disposition of real property for inadequate consideration where following a grant of a lease the balance is transferred to another person—Gift duty and income tax implications" was issued on 8 June 2005. The ruling’s subject matter was originally contained in BR Pub 02/03, which applied from 1 April 1999 to 31 March 2005. BR Pub 05/03 applies on 1 April 2005 for an indefinite period. It will appear in Inland Revenue’s Tax Information Bulletin, Vol. 17, No. 5, of June 2005.

3. A copy of the ruling may be obtained by writing to the Manager, Field Liaison & Communication (Adjudication & Rulings), National Office, Inland Revenue, P.O. Box 2198, Wellington.